These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 24517906
1. Time course analysis of the effects of botulinum neurotoxin type A on pain and vasomotor responses evoked by glutamate injection into human temporalis muscles. da Silva LB, Kulas D, Karshenas A, Cairns BE, Bach FW, Arendt-Nielsen L, Gazerani P. Toxins (Basel); 2014 Feb 10; 6(2):592-607. PubMed ID: 24517906 [Abstract] [Full Text] [Related]
2. Blockade of glutamate release by botulinum neurotoxin type A in humans: a dermal microdialysis study. Bittencourt da Silva L, Karshenas A, Bach FW, Rasmussen S, Arendt-Nielsen L, Gazerani P. Pain Res Manag; 2014 Feb 10; 19(3):126-32. PubMed ID: 24851237 [Abstract] [Full Text] [Related]
3. Botulinum neurotoxin type A (BoNTA) decreases the mechanical sensitivity of nociceptors and inhibits neurogenic vasodilation in a craniofacial muscle targeted for migraine prophylaxis. Gazerani P, Au S, Dong X, Kumar U, Arendt-Nielsen L, Cairns BE. Pain; 2010 Dec 10; 151(3):606-616. PubMed ID: 20728992 [Abstract] [Full Text] [Related]
4. Comparison of glutamate-evoked pain between the temporalis and masseter muscles in men and women. Castrillon EE, Cairns BE, Wang K, Arendt-Nielsen L, Svensson P. Pain; 2012 Apr 10; 153(4):823-829. PubMed ID: 22336721 [Abstract] [Full Text] [Related]
5. Effects of muscle pain induced by glutamate injections during sustained clenching on the contraction pattern of masticatory muscles. Michelotti A, Cioffi I, Rongo R, Borrelli R, Chiodini P, Svensson P. J Oral Facial Pain Headache; 2014 Apr 10; 28(3):252-60. PubMed ID: 25068219 [Abstract] [Full Text] [Related]
6. Muscle pain sensitivity after glutamate injection is not modified by systemic administration of monosodium glutamate. Shimada A, Castrillon E, Baad-Hansen L, Ghafouri B, Gerdle B, Ernberg M, Cairns B, Svensson P. J Headache Pain; 2015 Apr 10; 16():68. PubMed ID: 26197975 [Abstract] [Full Text] [Related]
7. Acupoint injection of onabotulinumtoxin A for migraines. Hou M, Xie JF, Kong XP, Zhang Y, Shao YF, Wang C, Ren WT, Cui GF, Xin L, Hou YP. Toxins (Basel); 2015 Oct 30; 7(11):4442-54. PubMed ID: 26529014 [Abstract] [Full Text] [Related]
8. Effects of subcutaneous administration of glutamate on pain, sensitization and vasomotor responses in healthy men and women. Gazerani P, Wang K, Cairns BE, Svensson P, Arendt-Nielsen L. Pain; 2006 Oct 30; 124(3):338-348. PubMed ID: 16919390 [Abstract] [Full Text] [Related]
9. Variation of pain and vasomotor responses evoked by intramuscular infusion of hypertonic saline in human subjects: influence of gender and its potential neural mechanisms. Lei J, You HJ. Brain Res Bull; 2012 Apr 10; 87(6):564-70. PubMed ID: 22100333 [Abstract] [Full Text] [Related]
10. The pro-algesic effect of γ-aminobutyric acid (GABA) injection into the masseter muscle of healthy men and women. Meijs S, Liao S, Arendt-Nielsen L, Wang K, Cairns BE. Scand J Pain; 2019 Dec 18; 20(1):139-150. PubMed ID: 31430257 [Abstract] [Full Text] [Related]
11. Intramuscular temperature modulates glutamate-evoked masseter muscle pain intensity in humans. Sato H, Castrillon EE, Cairns BE, Bendixen KH, Wang K, Nakagawa T, Wajima K, Svensson P. J Oral Facial Pain Headache; 2015 Dec 18; 29(2):158-67. PubMed ID: 25905534 [Abstract] [Full Text] [Related]
12. Early molecular response and microanatomical changes in the masseter muscle and mandibular head after botulinum toxin intervention in adult mice. Balanta-Melo J, Toro-Ibacache V, Torres-Quintana MA, Kupczik K, Vega C, Morales C, Hernández-Moya N, Arias-Calderón M, Beato C, Buvinic S. Ann Anat; 2018 Mar 18; 216():112-119. PubMed ID: 29289710 [Abstract] [Full Text] [Related]
13. Acidic saline-induced pain as a model for experimental masseter myalgia in healthy subjects. Castrillon EE, Cairns B, List T, Svensson P, Ernberg M. Eur J Pain; 2013 Nov 18; 17(10):1438-46. PubMed ID: 23649906 [Abstract] [Full Text] [Related]
15. The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization. Gazerani P, Staahl C, Drewes AM, Arendt-Nielsen L. Pain; 2006 Jun 18; 122(3):315-325. PubMed ID: 16677761 [Abstract] [Full Text] [Related]
16. Botulinum neurotoxin type A modulates vesicular release of glutamate from satellite glial cells. da Silva LB, Poulsen JN, Arendt-Nielsen L, Gazerani P. J Cell Mol Med; 2015 Aug 18; 19(8):1900-9. PubMed ID: 25754332 [Abstract] [Full Text] [Related]
17. Dose- and volume dependent-response to intramuscular injection of botulinum neurotoxin-A optimizes muscle force decrement in mice. Stone AV, Ma J, Callahan MF, Smith BP, Garrett JP, Smith TL, Koman LA. J Orthop Res; 2011 Nov 18; 29(11):1764-70. PubMed ID: 21491479 [Abstract] [Full Text] [Related]
18. Effects of OnabotulintoxinA on Habituation of Laser Evoked Responses in Chronic Migraine. de Tommaso M, Delussi M, Ricci K, Montemurno A, Carbone I, Vecchio E. Toxins (Basel); 2016 May 25; 8(6):. PubMed ID: 27231940 [Abstract] [Full Text] [Related]
19. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Silberstein SD, Stark SR, Lucas SM, Christie SN, Degryse RE, Turkel CC, BoNTA-039 Study Group. Mayo Clin Proc; 2005 Sep 25; 80(9):1126-37. PubMed ID: 16178492 [Abstract] [Full Text] [Related]
20. Serotonin, glutamate and glycerol are released after the injection of hypertonic saline into human masseter muscles - a microdialysis study. Louca S, Christidis N, Ghafouri B, Gerdle B, Svensson P, List T, Ernberg M. J Headache Pain; 2014 Dec 17; 15(1):89. PubMed ID: 25519464 [Abstract] [Full Text] [Related] Page: [Next] [New Search]